Article Listing - GlaxoSmithKline's R&D pipeline looks set to drive near-term growth

YUGOSLAV VACCINE PROGRAM

13 April 1992

ICN Pharmaceuticals of California and ICN-Galenika are to partly finance a project costing over $100,000 to vaccinate children in the...

GERMAN PANEL DOCTOR NUMBERS

13 April 1992

The rate of rise in the number of doctors in public-sector general practice registering in Germany is growing, says the...

SCHERING CORP TO MARKET FELBAMATE

13 April 1992

Schering Corp reports that it will have exclusive rights to market Carter-Wallace's N-methyl-D-aspartate receptor antagonist anticonvulsant felbamate worldwide, with the...

URIACH BUILDS NEW PLANT

13 April 1992

The Spanish pharmaceutical comp-any, Uriach, is constructing a new plant, reports the Spanish magazine Siete Dias Medicos.

The work is...

INTERNATIONAL INDUSTRY DISCUSSES JAPAN

13 April 1992

Representatives of the Japan Pharmaceutical Manufacturers Association, the European Busi-ness Council and the US Pharmaceutical Manufacturers Association met in Palm...

1991 A "SUPERB" YEAR FOR MARION MERRELL DOW

13 April 1992

Us pharmaceutical concern Marion Merrell Dow's second full year since its formation was a superb year financially, according to its...

OPTIMISTIC ANALYSIS OF WARNER-LAMBERT

13 April 1992

Despite the not so positive general consensus opinion on Warner-Lambert, analyst Jonathan Gelles at Wertheim Schroder is recommending purchase of...

NEW PRES AT JAPAN MEDICAL ASSOCIATION

13 April 1992

Toshiro Murase has been elected president of the Japan Medical Association, in succession to Haruto Haneda.

SCHWARZ PHARMA MAKES STRIDES IN EAST GERMANY

13 April 1992

The medium-sized German drugmaker Schwarz Pharma AG has criticized the 25% discount regulation applying to eastern German drugs sales. Board...

ISRAEL'S YISSUM R&D CO CLAIMS ACHIEVEMENTS

13 April 1992

Yissum is Israel's leading university R&D company, the Marketletter's local correspondent notes, and it offers more than 150 applied research...